Home › Trial NCT00465595
Psychopharmacology of Psilocybin in Cancer Patients
- Trial IDNCT00465595
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorJohns Hopkins University
- Enrollment56
- Start date2007-04
- ConditionsDepressive Symptoms · Anxiety · Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.